Subscribe to RSS
DOI: 10.1055/s-0040-1713443
Traumatic Chylothorax: Approach and Outcomes
Publication History
Publication Date:
31 July 2020 (online)
Abstract
Traumatic chylothorax occurs more often now than in historic reports. In part, this is due to the increased ability to perform more advanced and aggressive thoracic resections and cardiovascular surgeries as well as the improved mortality of cancer patients. If untreated, chylothorax can result in significant morbidity and mortality, particularly in patients with underlying malignancy. Thoracic duct embolization for chylothorax was the first successful lymphatic intervention and has been performed for over 20 years. An overview of the clinical and technical approach to thoracic duct embolization for traumatic chylothorax is presented in addition to a review of outcomes.
Keywords
chylothorax - thoracic duct embolization - iatrogenic - traumatic - postoperative - interventional radiologyDisclosures
All authors have read and contributed to this manuscript. The authors have no relevant disclosures. There was no grant funding or financial support for this manuscript.
-
References
- 1 Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84 (02) 129-133
- 2 Merigliano S, Molena D, Ruol A. , et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg 2000; 119 (03) 453-457
- 3 Majdalany BS, Murrey Jr DA, Kapoor BS. , et al; Expert Panel on Vascular Imaging and Interventional Radiology. ACR Appropriateness Criteria® chylothorax treatment planning. J Am Coll Radiol 2017; 14 (5S) S118-S126
- 4 Doerr CH, Allen MS, Nichols III FC, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80 (07) 867-870
- 5 Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH. Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 2010; 339 (04) 314-318
- 6 Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007; 32 (02) 362-369
- 7 Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999; 10 (09) 1248-1254
- 8 Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 2002; 13 (11) 1139-1148
- 9 Aalami OO, Allen DB, Organ Jr CH. Chylous ascites: a collective review. Surgery 2000; 128 (05) 761-778
- 10 Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic vessel network structure and physiology. Compr Physiol 2018; 9 (01) 207-299
- 11 Platis IE, Nwogu CE. Chylothorax. Thorac Surg Clin 2006; 16 (03) 209-214
- 12 Nix JT, Albert M, Dugas JE, Wendt DL. Chylothorax and chylous ascites; a study of 302 selected cases. Am J Gastroenterol 1957; 28 (01) 40-53 , discussion, 53–55
- 13 Savla JJ, Itkin M, Rossano JW, Dori Y. Post-operative chylothorax in patients with congenital heart disease. J Am Coll Cardiol 2017; 69 (19) 2410-2422
- 14 Oshikiri T, Takiguchi G, Miura S. , et al. thoracic duct resection during esophagectomy does not contribute to improved prognosis in esophageal squamous cell carcinoma: a propensity score matched-cohort study. Ann Surg Oncol 2019; 26 (12) 4053-4061
- 15 Bao T, Wang YJ, Li KK, Liu XH, Guo W. Short- and long-term outcomes of prophylactic thoracic duct ligation during thoracoscopic-laparoscopic McKeown esophagectomy for cancer: a propensity score matching analysis. Surg Endosc 2019; ; [Epub ahead of print]
- 16 Hung WT, Hung MH, Wang ML, Cheng YJ, Hsu HH, Chen JS. Nonintubated thoracoscopic surgery for lung tumor: seven years' experience with 1,025 patients. Ann Thorac Surg 2019; 107 (06) 1607-1612
- 17 Wu D, Chesnokova AE, Akvan S. , et al. Postoperative chylothorax after thoracoabdominal aortic aneurysm repair. Semin Thorac Cardiovasc Surg 2018; 30 (02) 215-219
- 18 Cope C. Percutaneous thoracic duct cannulation: feasibility study in swine. J Vasc Interv Radiol 1995; 6 (04) 559-564
- 19 Cope C. Percutaneous transabdominal embolization of thoracic duct lacerations in animals. J Vasc Interv Radiol 1996; 7 (05) 725-731
- 20 Rajebi MR, Chaudry G, Padua HM. , et al. Intranodal lymphangiography: feasibility and preliminary experience in children. J Vasc Interv Radiol 2011; 22 (09) 1300-1305
- 21 Nadolski GJ, Itkin M. Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization. J Vasc Interv Radiol 2012; 23 (05) 613-616
- 22 Meisinger QC, O'Brien S, Itkin M, Nadolski GJ. Use of sequential pneumatic compression devices to facilitate propagation of contrast during intranodal lymphangiography. J Vasc Interv Radiol 2017; 28 (11) 1544-1547
- 23 Mittleider D, Dykes TA, Cicuto KP, Amberson SM, Leusner CR. Retrograde cannulation of the thoracic duct and embolization of the cisterna chyli in the treatment of chylous ascites. J Vasc Interv Radiol 2008; 19 (2, Pt 1): 285-290
- 24 Guevara CJ, Rialon KL, Ramaswamy RS, Kim SK, Darcy MD. US-guided, direct puncture retrograde thoracic duct access, lymphangiography, and embolization: feasibility and efficacy. J Vasc Interv Radiol 2016; 27 (12) 1890-1896
- 25 Majdalany BS, Khayat M, Sanogo ML, Saad WE, Khaja MS. Direct trans-cervical endolymphatic thoracic duct stent-graft for plastic bronchitis. Lymphology 2018; 51 (03) 97-101
- 26 Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010; 139 (03) 584-589 , discussion 589–590
- 27 Pamarthi V, Stecker MS, Schenker MP. , et al. Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients. J Vasc Interv Radiol 2014; 25 (09) 1398-1404
- 28 Yannes M, Shin D, McCluskey K, Varma R, Santos E. Comparative analysis of Intranodal Lymphangiography with percutaneous intervention for postsurgical chylous effusions. J Vasc Interv Radiol 2017; 28 (05) 704-711
- 29 Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol 2018; 29 (02) 194-202.e4
- 30 Majdalany BS, Saad WA, Chick JFB, Khaja MS, Cooper KJ, Srinivasa RN. Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax. Pediatr Radiol 2018; 48 (02) 235-240
- 31 Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol 2012; 23 (01) 76-79